Sarah Ghosh

Sarah Ghosh

Sarah Ghosh serves as US Scientific Marketing Lead in Oncology at Regeneron, where she has been the driving commercial and scientific force behind the launch of LIBTAYO (cemiplimab) as a first-line treatment for advanced non-small cell lung cancer. Among her most notable achievements, Sarah was awarded Regeneron's Global Marketing Collaboration Award in Oncology, a recognition that speaks to both her cross-functional impact and her ability to lead at a global scale. She has built and managed Regeneron's peer-to-peer promotional education infrastructure from the ground up, including speaker bureau development, speaker training, live and virtual promotional programs, and US and Global Congress strategy. She has also led KOL identification, mapping, and engagement, and has been responsible for the development and execution of US commercial advisory boards that directly inform brand strategy. Her work spans the full commercial ecosystem, from HCP education to media and advertising investment, making her one of the most well-rounded scientific marketing leaders in oncology today.

Articles by Sarah Ghosh

Latest Updated Articles